CompletedNot Applicable

IVI Aflibercept Before and After Phaco in DME.

Kuwait40 participantsStarted 2019-09-01

Plain-language summary

To study whether or not cataract surgery should be deferred until treating the co-existing diabetic macular edema (DME) using intravitreal (IVI) anti-vascular endothelial growth factor (anti-VEGF).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- Diabetic patients with visually significant cataract Exclusion Criteria: * previous vitreoretinal surgery * laser or intravitreal injections 6 months prior to the procedure * intractable glaucom * active intra-ocular inflammation * retinal detachment * vitreous hemorrhage * epi-retinal membranes * any other retinal vascular or neuroretinal disease. * Patients with eventual cataract surgeries

What they're measuring

resolving of macular edema

Timeframe: Sixth month

Trial details

NCT IDNCT05731089

SponsorAl Hadi Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-08-01

View on ClinicalTrials.gov More Diabetic Macular Edema trials